Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea | Zendy

Mark H. Wilcox | Zendy

Open Access

Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea

Author(s) -

Mark H. Wilcox

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh285

Subject(s) - medicine , piperacillin/tazobactam , piperacillin , cefotaxime , tazobactam , incidence (geometry) , clostridium difficile , antibiotics , intensive care medicine , microbiology and biotechnology , antibiotic resistance , imipenem , genetics , physics , optics , bacteria , pseudomonas aeruginosa , biology

We followed the effects of changes to a new antibiotic policy favouring a ureidopenicillin as opposed to a third-generation cephalosporin on the long-term incidence of Clostridium difficile diarrhoea (CDD) and antibiotic utilization in a large Elderly Medicine Unit.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research